Physician profile
Anjan Kumar Sinha
NPI 1033209515
$53,818.33
in general payments reported to CMS, 2019-2025
28 companies · $4,473 in 2025
The $4,473 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $6,569 · 2021: $2,548 · 2022: $9,096 · 2023: $3,687 · 2024: $1,081 · 2025: $4,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,355 · Travel and Lodging: $2,637 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,354.75 |
| Travel and Lodging | $2,636.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $23,408.29 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Rotapro |
| Edwards Lifesciences Corporation | $16,396.01 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Cardiovascular Systems INC. | $7,684.79 | 2019-2020 | |
| Abbott Laboratories | $3,349.98 | 2019-2025 | Mitraclip, Amplatzer Amulet, Cardiomems |
| Abiomed | $1,017.06 | 2019-2025 | Impella |
| Medtronic, INC. | $450.71 | 2021-2025 | Corevalve Evolut R, Ffrangio, Onyx Frontier |
| Shockwave Medical, INC | $200.80 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $177.08 | 2021-2023 | Brilinta |
| Novo Nordisk INC | $133.01 | 2023-2024 | Ozempic |
| Biotronik INC. | $122.73 | 2023 | Orsiro Mission |
| Cardiva Medical, INC. | $101.32 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs, Ensoetm |
| Pfizer INC. | $94.79 | 2023-2025 | |
| Terumo Medical Corporation | $88.04 | 2020-2025 | Azur Cx Detachable |
| Cordis US Corp. | $80.87 | 2023-2025 | Mynx Control Venous, Mynx Venous Vcd, Rain Sheath Transradial |
| Amgen INC. | $77.95 | 2023-2024 | Repatha |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $77.83 | 2023-2025 | Lifevest |
| Medtronic Vascular, INC. | $71.92 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $64.93 | 2022-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $44.12 | 2022-2025 | Eliquis |
| Siemens Medical Solutions USA, INC. | $26.78 | 2023 | Artis Icono Floor |
| Teleflex LLC | $23.34 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.25 | 2023 | Jardiance |
| Biosense Webster, INC. | $20.99 | 2021 | |
| Philips North America LLC | $19.08 | 2023 | |
| Zoll Circulation INC | $17.89 | 2025 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Actelion Pharmaceuticals US, INC. | $17.50 | 2025 | Uptravi, Opsumit |
| Kestra Medical Technology Services, INC. | $14.62 | 2023 | Assure Wcd |
| Merck Sharp & Dohme LLC | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anjan Sinha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.